Skip to content

A real-world cohort study of gastric cancer diagnosis and treatment scheme

A real-world cohort study of gastric cancer diagnosis and treatment scheme

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079023
Enrollment
Unknown
Registered
2023-12-23
Start date
2023-12-25
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Exposed group (use YQHYJD decoction):N/A
control group (do not use YQHYJD decoction):N/A

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The pathological diagnosis meets the diagnostic criteria for gastric cancer; (2) Patients who have undergone radical surgery for gastric cancer; (3) Sign the informed consent form. Volunteer subjects. The process of obtaining informed consent shall comply with GCP.

Exclusion criteria

Exclusion criteria: (1) Patients with metastatic gastric cancer; (2) Patients with local recurrence or distant metastasis who have been identified by histopathology or imaging examination; (3) Patients participating in clinical studies of other drugs.

Design outcomes

Primary

MeasureTime frame
disease-free survival;

Secondary

MeasureTime frame
Tumor markers;Quality of life score;Overall chemotherapy completion rate;

Countries

China

Contacts

Public ContactPeng Shu

Department of Oncology, Jiangsu Province Hospital of Chinese Medicine

shupengnjucm@163.com+86 138 5170 1678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026